Barriers and facilitators to anal cancer screening among people living with HIV in Puerto Rico
Authors:
- Gabriela CruzGCGabriela Cruz
- Jeslie M. Ramos-CartagenaJRJeslie M. Ramos-Cartagena
- José L. Torres-RusseJTJosé L. Torres-Russe
- Vivian Colón-LópezVCVivian Colón-López
- Karen J. Ortiz-OrtizKOKaren J. Ortiz-Ortiz
- Luis PericchiLPLuis Pericchi
- Ashish A. DeshmukhADAshish A. Deshmukh
- Ana Patricia OrtizAOAna Patricia Ortiz
Open Access
- 6 October 2023
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 23 (1) , 1-12
Abstract
Background: Anal cancer (AC) disproportionally affects people living with HIV (PLWH). Although there are no consensus-based AC screening guidelines, experts recommend anal pap as a primary screening tool in settings where high-resolution anoscopy (HRA) is available. We aimed to assess barriers and facilitators to anal cancer screening in a sample of Hispanic PLWH in Puerto Rico. Methods: To assess their knowledge and attitudes, we conducted a cross-sectional survey from 2020–2021 among PLWH in Puerto Rico (n = 212). Data was collected through a telephone interview that assessed information on sociodemographics, knowledge, and attitudes about AC, and the history of AC screening. The chi-square test, Fisher exact test, and logistic regression models were used to assess factors associated with screening uptake. Results: Anal Pap and HRA awareness were 60.4% and 30.7%, respectively. Anal Pap and HRA uptake was 51.5% and 19.3%, respectively. The most common barriers for anal Pap and HRA were lack of knowledge about the test and lack of physician recommendation. MSM were more likely to have heard of anal Pap (OR: 2.15, 95% CI:1.30–3.54) than MSW. MSM (OR: 3.04, 95% CI: 1.79–5.19) and women (OR: 3.00, 95% CI: 1.72–5.20) were also more likely to have undergone anal Pap. Similarly, individuals with a history of genital warts were more likely to have heard of anal Pap and HRA and have undergone anal Pap and HRA. Awareness of where to go for concerns about anal health was positively associated with having received anal Pap and HRA. Conclusions: With emerging evidence on the effectiveness of screening and treatment for anal cancer, several organizations are steering toward generating consensus-based anal cancer screening recommendations. Our study provides foundational data on barriers and facilitators to anal cancer screening in Puerto Rico that will be critical to informing screening implementation in this US territory.Keywords
Funding Information
- Division of Cancer Prevention, National Cancer Institute (R25CA240120, 2U54CA096297–18, R25CA240120, 2U54CA096297–18, 2U54CA096297–18, 2U54CA096297–18, 2U54CA096297–18, R25CA240120)
This publication has 37 references indexed in Scilit:
- Cervical Cancer Screening Barriers and Risk Factor Knowledge Among Uninsured WomenJournal of Community Health, 2017
- 2016 IANS International Guidelines for Practice Standards in the Detection of Anal Cancer PrecursorsJournal of Lower Genital Tract Disease, 2016
- A prospective study of anal cancer screening in HIV-positive and negative MSMAIDS, 2016
- Exploring the Perceptions of Anal Cancer Screening and Behaviors among Gay and Bisexual Men Infected with HIVCancer Control, 2016
- Beliefs About Anal Cancer among HIV-Infected Women: Barriers and Motivators to Participation in ResearchWomen's Health Issues, 2015
- Screening to prevent anal cancer: Current thinking and future directionsCancer Cytopathology, 2015
- Why are we not screening for anal cancer routinely - HIV physicians’ perspectives on anal cancer and its screening in HIV-positive men who have sex with men: a qualitative studyBMC Public Health, 2015
- Women’s Knowledge and Attitudes Toward Anal Pap TestingJournal of Lower Genital Tract Disease, 2013
- Participants’ perspectives of high resolution anoscopySexual Health, 2011
- Gay and Bisexual Men's Willingness to Receive Anal Papanicolaou TestingAmerican Journal of Public Health, 2010